The value of a company hinges on its scale (measured in units such as sales or EBITDA), its quality, the price buyers are willing to pay per unit of scale (e.g., price-per-crore of EBITDA), and, in certain cases, its breakup value.
To generate profits for their investors, GPs focus on increasing the scale of companies, improving their quality, raising the price buyers are prepared to pay per unit of scale, and, occasionally, transferring wealth from the companies to individual investors.
GPs in VC/PE employ six broad strategies to create returns on their investments. The value bridge analysis in Chart 1 below offers a visual summary of how these strategies contributed to an actual Growth PE transaction. In this example, the majority of the exit gain came from increased sales (larger scale), followed by an improved valuation multiple (higher price-per-unit), and enhanced efficiency reflected in a stronger EBITDA margin (improved quality).
The significance of each strategy and its typical contribution to total returns in a VC/PE investment varies depending on the company’s growth stage.
Moreover, individual GPs may favour specific combinations of these strategies based on their unique expertise and experience.
At Oister, we believe that understanding which strategies are most relevant at different stages of a company’s growth—and which strategies individual GPs favor—provides critical insights for managing VC and PE investments effectively.
Table 1 below summarises the six strategies employed by GPs:
Organic revenue refers to the revenue generated through a company’s own operations, as opposed to revenue acquired via M&A. GPs aim to achieve greater scale by driving organic growth. To boost sales, GPs may identify new markets, introduce new products, or leverage their networks to connect companies with potential buyers. Organic revenue growth plays a pivotal role in driving EBITDA growth and is a critical contributor to returns at all stages of VC and PE, except for LBOs.
Inorganic revenue is added through acquisitions. GPs help their companies scale by identifying and executing acquisition opportunities. These acquisitions enable faster scaling and often improve margins by eliminating duplicate operations.
EBITDA can grow through increased revenue or enhanced efficiency. GPs work closely with companies to identify and implement efficiency improvements. For instance, optimising supply chains can reduce production costs and enhance gross margins, while cutting operating costs such as rent, utilities, and labour can boost operating margins.
The valuation multiple represents the price investors are willing to pay per unit of a company’s operating or financial metric (e.g., sales or EBITDA). For mature companies, metrics like earnings inform well-known ratios such as Price/Earnings (P/E). For earlier-stage companies, Price/Sales may apply, while for very early-stage ventures, valuation multiples are intangible and based on perceived potential and probability of achieving scale.
While valuation multiples are heavily influenced by market sentiment and largely outside GPs’ control, they can still employ strategies to enhance these multiples. For example, they might collaborate with successful repeat entrepreneurs, onboard respected investors, secure contracts with prominent brands, or achieve growth milestones. Larger companies also tend to command higher multiples, so GPs often focus on scaling companies to a size where a step-up in the valuation multiple adds to investor returns.
A company’s capital structure affects both its return on equity and risk profile. Higher debt-to-equity ratios can amplify returns during profitable periods by distributing profits among fewer equity holders but increase risk during downturns due to fixed debt servicing costs. The use of leverage typically increases as companies grow larger and their cash flows become more predictable.
Cash distributions transfer wealth from the company to its investors through dividends or share buybacks. This strategy is most suitable for companies with excess cash reserves that are not required for reinvestment in the business.
As the examples below illustrate, GP’s typically employ several strategies in each investment.
Chart 2 provides a broad indication of the relative importance of the six strategies across the VC/PE spectrum. Since there isn’t a perfect alignment between company growth stages and these strategies, the chart serves as a general guide.
At the Seed stage, a company typically has a vision but is still exploring product-market fit or conducting research. Without a defined business model or accounting metrics, valuation hinges on the strength of the vision—market potential, founder expertise, and the credibility of financial backers.
As the company begins generating revenue, it signals proof of demand and validation of its vision. Early revenue growth is often organic, driven by the company’s own activities. Organic growth remains a key strategy and a critical contributor to returns across all VC stages and into mid-cap PE.
Once the business model solidifies—complete with a clear go-to-market strategy and established unit economics—the company can start exploring acquisitions. This clarity, typically achieved by Series-C, allows a company to pursue both organic and inorganic growth through M&A. Acquiring other businesses can boost revenue and enhance margins by reducing duplicate costs during consolidation.
As companies scale, investors begin to shift focus beyond sales volumes to evaluate the quality of recurring revenue. This includes assessing production costs and operational efficiency. By this stage, the market for the company’s goods or services is proven, but competitiveness and sustainable margins become critical. Operational efficiency becomes a key focus for later-stage VC-backed companies and remains a significant strategy for PE firms acquiring mature businesses.
Debt plays a role in creating value for equity investors at all stages. For instance, early-stage VC-backed companies in Series A often utilise venture debt to fund growth while minimizing equity dilution. However, active capital structure management gains prominence only when companies have predictable revenues and sufficient scale for lenders to underwrite. This typically begins around Series D-E for VC-backed companies. In PE, debt is a value-creation tool at all stages and becomes a dominant strategy in leveraged buyouts (LBOs).
The final strategy—extracting cash through dividends or share buybacks—is viable only for mature companies with steady cash flows and surplus funds that aren’t needed for reinvestment. Growth-focused companies, from early stages through growth PE, are less likely to have large surpluses for distribution. Consequently, cash extraction is predominantly employed in large PE strategies, especially LBO funds.
TERMS OF USE
Thank you for your interest in our Website at https://unlistedintel.com/. Your use of this Website, including the content, materials and information available on or through this Website (together, the “Materials”), is governed by these Terms of Use (these “Terms”). By using this Website, you acknowledge that you have read and agree to these Terms.
NO OFFER, SOLICITATION OR ADVICE
Our site is provided for informational purposes only. It does not constitute to constitute (i) an offer, or solicitation of an offer, to
purchase or sell any security, other assets, or service, (ii) investment, legal, business, or tax advice, or an offer to provide such advice or (iii) a basis for making any investment decision.
The Materials are provided for informational purposes and have been prepared by Oister Global for informational purposes to acquaint existing and prospective underlying funds, entrepreneurs, and other company founders with Oister Global's recent and historical investment activities.
Please note that any investments or portfolio companies referenced in the Materials are illustrative and do not reflect the performance of any Oister Global fund as a whole. There is no obligation for Oister Global to update or alter any forward-looking statements, whether as a result of new information, future events, or otherwise.
PURPOSE LIMITATION AND ACCESS TO YOUR PERSONAL DATA:
We will only collect your personal data in a fair, lawful, and transparent manner. We will keep your personal data accurate and up to date. We will process your personal data in line with your legal rights. We use your name and contact details, such as email, postal address, and contact number to continue communications with you. We may also use your contact information to invite you to events we are hosting or to keep you updated with our news.
USE OF COOKIES OR SIMILAR DEVICES
We use cookies on our website. This helps us to provide you with a better experience when you browse our website and also allows us to make improvements to our site. You may be able to change the preferences on your browser or device to prevent or limit your device’s acceptance of cookies, but this may prevent you from taking advantage of some of our features.
MATERIAL
The material displayed on our site is provided “as is”, without any guarantees, conditions, or warranties as to its accuracy, completeness, or reliability. You should be aware that a significant portion of the Materials includes or consists of information that has been provided by third parties and has not been validated or verified by us. In connection with our investment activities, we often become subject to a variety of confidentiality obligations to funds, investors, portfolio companies, and other third parties. Any statements we make may be affected by those confidentiality obligations, with the result that we may be prohibited from making full disclosures.
MISCELLANEOUS
This Website is operated and controlled by Oister Global in India. We may change the content on our site at any time. If the need arises, we may suspend access to our site, or close it indefinitely. We are under no obligation to update any material on our site.
CONTACT INFORMATION
Any questions, concerns or complaints regarding these Terms should be sent to info@oisterglobal.com